RAYLYTIC
Leipzig
About RAYLYTIC
Raylytic develops the only fully integrated platform for automated medical image analysis and clinical data extraction. They develop UNITY, the only fully integrated software platform that streamlines the setup and conduct of clinical data collection tasks, including CRFs, PROMs and AI-based medical image analysis. UNITY is utilized to operate private registries, to conduct clinical trials for regulatory approval, post-market surveillance and general medical data collection tasks, providing the basis for evidence based medicine and the backing of product claims with documented, traceable scientific substantiation. Their modular framework utilizes algorithms from industrial and medical image processing as well as sophisticated machine learning algorithms, allowing for the first time the highly automated data extraction and quantification of endpoints based on medical images. The most recent addition is their Clinical Data Module, which seamlessly integrates the electronic capture of patient reported outcome measures (PROMs) into the clinical routine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $10.3M
- Funding stage: Seed
- Last round: Convertible Note (Mar 2023)
- Website: raylytic.com
- Phone: +49 (341) 656702-0
Industries & Categories
Artificial Intelligence (AI), Big Data, Clinical Trials, Electronic Health Record (EHR), Health Care
Social Profiles
Canonical: https://fsome.com/organization/raylytic-6308 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.